CoreWeave, Inc. filings document the regulatory record for an AI cloud infrastructure company listed on Nasdaq with Class A common stock. The company’s 8-K reports cover operating results, customer cloud-capacity agreements, private placements of equity securities, senior notes, credit facilities, and related guarantees or collateral arrangements.
Proxy materials disclose annual meeting matters, stockholder voting items, board governance, executive compensation, and equity-award information. Capital-structure filings describe senior unsecured notes due 2031, subsidiary guarantees, private placement registration rights, and debt facilities used to finance GPU servers and related infrastructure for customer contracts.
A shareholder of CRWV filed a notice to sell up to 40,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of about $2,928,400, after 07/20/2026 on NASDAQ.
The filing classifies the securities as “Founders Shares” originally acquired on 02/25/2019. It also lists extensive prior Rule 10b5-1 plan sales during the past three months by various related holders and trusts. Reported total shares outstanding are 447,573,939.
CRWV filed a notice of proposed sale of common stock. The filing lists 12,500 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services at an aggregate value of $915,125.00, with a proposed sale date of July 20, 2026 on NASDAQ.
The filing also details extensive Rule 10b5-1 trading plan sales of CRWV common stock over the past three months by Brannin McBee, Meghan Bennett and several related trusts and entities. Individual transactions include, for example, a 200,000-share sale for $21,806,780.00 on April 27, 2026 and recurring 144,000-share sales on multiple June and July 2026 dates.
A holder of CRWV common stock filed to sell 25,000 founders’ shares through Morgan Stanley Smith Barney, with an aggregate market value of $1,830,250, on or after July 20, 2026 under Rule 144. The filing also lists extensive recent Rule 10b5-1 plan sales of CRWV common stock by Brannin McBee, Meghan Bennett and related trusts over the past three months, detailing multiple transactions in blocks up to 200,000 shares each.
CoreWeave CEO and President Michael N. Intrator, a more-than-10% stockholder, reported several open-market transactions in the company’s Class A Common Stock on July 14, 2026. Through Omnadora Capital LLC and direct holdings, entities associated with him sold a total of 307,692 Class A shares at weighted-average prices between $78.48 and $85.78 per share, with certain sales executed pursuant to a Rule 10b5-1 trading plan adopted on November 20, 2025.
The filing also reports the conversion of 107,692 shares of Class B Common Stock held indirectly through Omnadora into Class A. After these transactions, Intrator continues to hold substantial equity, including 2,676,815 Class A shares directly, 21,867,489 Class B shares directly (each convertible 1-for-1 into Class A), and additional Class B positions held by his spouse and family trusts.
CoreWeave, Inc. Chief Development Officer Brannin McBee reported indirect transactions in Class A and Class B Common Stock on July 13, 2026. Family and grantor retained annuity trusts associated with McBee sold a total of 53,000 Class A shares in multiple open-market trades and converted 52,500 Class B shares into Class A. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2026, and related trusts continue to hold Class A positions, including 6,408 shares in the Canis Minor 2025 GRAT, 20,502 shares in the Canis Major 2025 GRAT and 51,259 shares in the Canis Major SM Trust.
CoreWeave, Inc. Chief Development Officer Brannin McBee and related entities reported multiple transactions in CoreWeave Class A and Class B Common Stock on July 13, 2026. The filing shows 197,000 Class A shares sold in open‑market transactions and 197,000 Class B shares converted into Class A.
After these transactions, McBee holds 323,263 Class A shares directly and 6,186,894 Class B shares directly, with additional Class B holdings held through trusts and a spouse. A footnote notes that at least one reported sale was effected pursuant to a Rule 10b5‑1 trading plan adopted on March 5, 2026.
CoreWeave, Inc. reported that Chief Financial Officer Nitin Agrawal sold 65,055 shares of Class A Common Stock on July 13, 2026 in a series of open‑market sales executed under a pre‑arranged Rule 10b5‑1 trading plan, at weighted average prices between $83.2595 and $88.2505 per share, with underlying trades occurring within price ranges from $82.80 to $88.79 per share as described in the footnotes.
Following these sales, Agrawal holds 128,716 shares directly and additional indirect interests, including 57,952 shares in a Yosemite 2025 GRAT, 81,000 shares in a Yellowstone 2025 GRAT, and 34,905 shares held by his spouse.
CRWV filed a Form 144 notice covering the proposed sale of 200000 shares of common stock, with an aggregate market value of $16662000.00, to be sold through Morgan Stanley Smith Barney LLC on or after 07/14/2026 on NASDAQ.
The shares to be sold were acquired on 02/25/2019 via a Preferred Stock Conversion from the issuer. Total common shares outstanding were 447573939; this is a baseline figure, not the amount being offered. The disclosure also lists numerous recent transactions, including Rule 10b5-1 sales by holders such as Michael Intrator and Omnadora Capital LLC.
A holder of CRWV common stock plans to sell 107,692 shares, with an indicated aggregate market value of $8,971,820.52, and sales expected to begin on 07/14/2026 on NASDAQ. These shares are described as founder shares acquired from the issuer on 11/13/2017.
The disclosure also lists numerous transactions over the past three months labeled as 10b5-1 Sales for Michael Intrator and Omnadora Capital LLC, including repeated 200,000-share and 107,692-share sales, along with one transaction for Fidelity Charitable.
CRWV received a notice of proposed sale of common stock under Rule 144. A holder plans to sell 25,000 common shares of CRWV through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated value of $2,222,000.00 and listing on NASDAQ as of 07/13/2026.
The filing also lists extensive Rule 10b5-1 sales of CRWV common stock during the past three months by Brannin McBee, Meghan Bennett and several related trusts and entities, with individual transactions as large as 200,000 shares on single days under pre-arranged trading plans.